Earnings History Data for United Therapeutics Corporation (UTHR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

United Therapeutics Corporation

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	PM		UTHR	United Therapeutics Corporation	15,560	6.39	6.16	5.38	United Therapeutics GAAP EPS of $6.39 misses by $0.03, revenue of $748.9M beats by $26.09M [10/30/2024 6:30 AM]	361.78	8.98 (2.55%)	359.00	6.20 (1.76%)	208.62 - 377.03	422,974	350,000	1,128
United Therapeutics Q3 2024 Earnings Preview [10/29/2024 3:38 PM] United Therapeutics GAAP EPS of $6.39 misses by $0.03, revenue of $748.9M beats by $26.09M [10/30/2024 6:30 AM] United Therapeutics Corporation Reports Third Quarter 2024 Financial Results [2024-10-30 06:30AM] Curious about United Therapeutics (UTHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics [Oct-29-24 09:15AM]
31-07-2024	PM		UTHR	United Therapeutics Corporation	14,870	5.85	6.33	5.24	United Therapeutics GAAP EPS of $5.85 misses by $0.55, revenue of $714.9M beats by $24.05M [7/31/2024 6:35 AM]	313.43	-24.11 (-7.14%)	325.00	-12.54 (-3.72%)	208.62 - 343.98	782,850	420,000	2,305
United Therapeutics Q2 2024 Earnings Preview [7/30/2024 12:46 PM] United Therapeutics GAAP EPS of $5.85 misses by $0.55, revenue of $714.9M beats by $24.05M [7/31/2024 6:35 AM]
01-05-2024	PM		UTHR	United Therapeutics Corporation	11,210	6.17	5.63	4.86	United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M [5/1/2024 6:37 AM]	255.25	20.92 (8.93%)	242.24	7.91 (3.38%)	204.44 - 261.54	1,069,907	510,000	5,117
United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M [5/1/2024 6:37 AM] United Therapeutics Q1 2024 Earnings Preview [4/30/2024 11:53 AM]
21-02-2024	PM		UTHR	United Therapeutics Corporation	10,090	4.36	3.92	2.67	United Therapeutics GAAP EPS of $4.36 beats by $0.17, revenue of $614.7M beats by $38.83M [2/21/2024 6:02 AM]	219.30	5.14 (2.40%)	205.06	-9.10 (-4.25%)	204.44 - 261.54	531,296	350,000	0
United Therapeutics Q4 2023 Earnings Preview [2/20/2024 11:20 AM] United Therapeutics GAAP EPS of $4.36 beats by $0.17, revenue of $614.7M beats by $38.83M [2/21/2024 6:02 AM]
01-11-2023	PM		UTHR	United Therapeutics Corporation	10,350	5.38	4.89	4.91	United Therapeutics GAAP EPS of $5.38 beats by $0.34, revenue of $609.4M beats by $23.58M [11/1/2023 6:04 AM]	224.06	1.20 (0.54%)	223.00	0.14 (0.06%)	204.44 - 283.09	954,386	260,000	12,702
United Therapeutics Q3 2023 Earnings Preview [10/31/2023 12:39 PM] Second person to get pig heart transplant dies [11/1/2023 4:17 AM] United Therapeutics GAAP EPS of $5.38 beats by $0.34, revenue of $609.4M beats by $23.58M [11/1/2023 6:04 AM]
02-08-2023	PM		UTHR	United Therapeutics Corporation	11,370	5.24	4.41	2.41	United Therapeutics beats Q2 top and bottom line estimates [8/2/2023 6:02 AM]	241.22	1.09 (0.45%)	260.00	19.87 (8.27%)	201.65 - 283.09	864,016	300,000	6,690
United Therapeutics Q2 2023 Earnings Preview [8/1/2023 1:28 PM] United Therapeutics beats Q2 top and bottom line estimates [8/2/2023 6:02 AM]
03-05-2023	PM	6:00 AM ET (May 3)	UTHR	United Therapeutics Corporation	10,750	4.86	4.26	5.03	United Therapeutics GAAP EPS of $4.86 beats by $0.36, revenue of $506.9M misses by $7.47M [5/3/2023 6:05 AM]	218.89	-9.90 (-4.33%)	0.0	0.0 (0.00%)	174.36 - 283.09	802,283	390,000	0
United Therapeutics Q1 2023 Earnings Preview [5/2/2023 1:05 PM] United Therapeutics GAAP EPS of $4.86 beats by $0.36, revenue of $506.9M misses by $7.47M [5/3/2023 6:05 AM]
22-02-2023	PM	6:00 AM ET (Feb 22)	UTHR	United Therapeutics Corporation	11,460	2.67	4.12	2.35	United Therapeutics GAAP EPS of $2.67 misses by $1.83, revenue of $491.5M misses by $27.7M [2/22/2023 6:02 AM]	243.69	-11.56 (-4.53%)	240.06	-15.19 (-5.95%)	158.38 - 283.09	790,469	440,000	14,614
United Therapeutics GAAP EPS of $2.67 misses by $1.83, revenue of $491.5M misses by $27.7M [2/22/2023 6:02 AM] United Therapeutics Q4 2022 Earnings Preview [2/21/2023 12:46 PM]
02-11-2022	PM	6:00 AM ET (Nov 2)	UTHR	United Therapeutics Corporation	10,490	4.91	3.57	3.42	United Therapeutics GAAP EPS of $4.91 beats by $1.10, revenue of $516M beats by $22.54M [11/2/2022 6:02 AM]	254.21	25.82 (11.31%)	228.39	0.0 (0.00%)	158.38 - 259.18	1,561,719	290,000	3,676
United Therapeutics GAAP EPS of $4.91 beats by $1.10, revenue of $516M beats by $22.54M [11/2/2022 6:02 AM] United Therapeutics surges 12% on Q3 beat as Tyvaso drives sales growth [11/2/2022 12:16 PM] United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference [Nov-01-22 06:00AM]
03-08-2022	PM	6:00 AM ET (Aug 3)	UTHR	United Therapeutics Corporation	10,210	2.41	4.10	3.65	United Therapeutics GAAP EPS of $2.41 misses by $1.55, revenue of $466.9M beats by $5.84M [8/3/2022 6:02 AM]	228.78	4.03 (1.79%)	224.75	0.0 (0.00%)	158.38 - 245.48	529,336	380,000	6,930
United Therapeutics Q2 2022 Earnings Preview [8/2/2022 2:13 PM] United Therapeutics GAAP EPS of $2.41 misses by $1.55, revenue of $466.9M beats by $5.84M [8/3/2022 6:02 AM]
04-05-2022	PM	6:00 AM ET (May 4)	UTHR	United Therapeutics	8,014	5.03	2.96	0.00	United Therapeutics GAAP EPS of $5.03 beats by $1.96, revenue of $461.9M beats by $41.88M [5/4/2022 6:03 AM]	185.53	5.85 (3.26%)	179.68	0.0 (0.00%)	158.38 - 218.38	567,334	340,000	7,578
United Therapeutics Q1 2022 Earnings Preview [5/3/2022 11:58 AM] United Therapeutics GAAP EPS of $5.03 beats by $1.96, revenue of $461.9M beats by $41.88M [5/4/2022 6:03 AM] United Therapeutics Corporation Reports First Quarter 2022 Financial Results [May-04-22 06:00AM] United Therapeutics (UTHR) Q1 Earnings and Revenues Surpass Estimates [May-04-22 07:15AM] United Therapeutics reports 'best quarter' to date. Heres what comes next. [May-04-22 02:38PM]
24-02-2022	PM	6:00 AM ET (Feb 24)	UTHR	United Therapeutics Corporation	8,720	2.35	3.77	2.19	United Therapeutics Non-GAAP EPS of $3.51 misses by $0.54, revenue of $415.2M misses by $12.39M [2/24/2022 6:03 AM]	168.04	-25.07 (-12.98%)	0.0	0.0 (0.00%)	155.71 - 218.38	1,358,771	392,411	0
United Therapeutics Q4 2021 Earnings Preview [2/23/2022 12:05 PM] United Therapeutics Non-GAAP EPS of $3.51 misses by $0.54, revenue of $415.2M misses by $12.39M [2/24/2022 6:03 AM] United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-24-22 06:00AM] United Therapeutics (UTHR) Misses Q4 Earnings and Revenue Estimates [Feb-24-22 07:15AM]
03-11-2021	PM	6:00 AM ET (Nov 3)	UTHR	United Therapeutics Corporation	8,700	3.42	3.37	3.84	United Therapeutics EPS beats by $0.07, beats on revenue [11/3/2021 6:13 AM]	203.27	11.08 (5.76%)	193.00	0.80 (0.42%)	129.43 - 216.90	750,728	450,000	4,320
United Therapeutics Q3 2021 Earnings Preview [11/2/2021 10:23 AM] United Therapeutics EPS beats by $0.07, beats on revenue [11/3/2021 6:13 AM] United Therapeutics Corporation Reports Third Quarter 2021 Financial Results [Nov-03-21 06:00AM] United Therapeutics (UTHR) Q3 Earnings and Revenues Surpass Estimates [Nov-03-21 07:15AM] United Therapeutics Corporation (UTHR) Q3 2021 Earnings Call Transcript [Nov-03-21 12:01PM]
04-08-2021	PM	6:00 AM ET (Aug 4)	UTHR	United Therapeutics Corporation	8,060	3.65	2.86	2.41	United Therapeutics EPS beats by $0.53, beats on revenue [8/4/2021 6:03 AM]	206.09	25.43 (14.08%)	206.09	0.0 (0.00%)	98.37 - 212.62	1,589,541	220,000	5,734
United Therapeutics Q2 2021 Earnings Preview [8/3/2021 1:49 PM] United Therapeutics EPS beats by $0.53, beats on revenue [8/4/2021 6:03 AM] United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference [Aug-03-21 06:00AM] United Therapeutics Corporation Reports Second Quarter 2021 Financial Results [Aug-04-21 06:00AM] United Therapeutics (UTHR) Q2 Earnings and Revenues Surpass Estimates [Aug-04-21 07:15AM] United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call Transcript [Aug-04-21 12:30PM] Why United Therapeutics Blasted 14% Higher Today [Aug-04-21 05:56PM]
05-05-2021	PM	6:00 AM ET (May 5)	UTHR	United Therapeutics Corporation	8,980	0.61	2.60	3.12	United Therapeutics EPS in-line, beats on revenue [5/5/2021 6:01 AM]	198.14	2.77 (1.42%)	198.14	0.0 (0.00%)	98.37 - 212.62	406,467	250,000	4,439
United Therapeutics Q1 2021 Earnings Preview [5/4/2021 1:00 PM] United Therapeutics EPS in-line, beats on revenue [5/5/2021 6:01 AM] United Therapeutics Corporation Reports First Quarter 2021 Financial Results [May-05-21 06:00AM] United Therapeutics Corp. to Host Earnings Call [May-05-21 07:15AM] United Therapeutics (UTHR) Lags Q1 Earnings Estimates [May-05-21 07:30AM] United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript [May-05-21 03:01PM]
24-02-2021	PM	6:00 AM ET (Feb 24)	UTHR	United Therapeutics Corporation	7,750	2.19	2.96	1.20	United Therapeutics EPS misses by $0.20, beats on revenue [2/24/2021 6:06 AM]	173.90	1.52 (0.88%)	172.38	0.0 (0.00%)	75.58 - 181.14	380,203	284,896	4,751
United Therapeutics EPS misses by $0.20, beats on revenue [2/24/2021 6:06 AM] United Therapeutics Q4 2020 Earnings Preview [2/23/2021 11:26 AM] BTIG sees bullish future for MannKind, doubles price target as shares surge [2/24/2021 11:15 AM] United Therapeutics Corp. to Host Earnings Call [Feb-24-21 07:15AM]
28-10-2020	PM	6:00 AM ET (Oct 28)	UTHR	United Therapeutics Corporation	5,490	3.84	2.41	3.01	United Therapeutics EPS beats by $0.54, beats on revenue [10/28/2020 6:04 AM]	132.09	8.69 (7.04%)	123.40	0.0 (0.00%)	75.58 - 132.99	1,085,972	574,028	9,489

29-07-2020	PM	6:00 AM ET (Jul 29)	UTHR	United Therapeutics Corporation	5,050	2.41	2.41	4.66	United Therapeutics EPS beats by $0.41, beats on revenue [7/29/2020 6:05 AM]	113.11	-0.05 (-0.04%)	116.00	2.84 (2.51%)	75.58 - 127.79	322,315	343,051	2,542